论文部分内容阅读
目的:比较食管癌两切口术后病人早期经鼻肠管和空肠造口管途径行EN支持的方便性、优越性和并发症。方法:选择食管癌两切口手术病人共52例,随机分为三组:A组为鼻肠管组;B组为空肠造口管组;C组为对照组。分别记录术中鼻肠管和空肠造口管的放置时间、观察EN支持期间的临床表现和术后并发症,并测定EN支持前后病人的血糖、肝肾功能、电解质和营养指标等。结果:在研究期间所有病人无死亡,无严重并发症,无明显肝肾功能改变。A组术中放置鼻肠管时间为(22.1±5.9)min;B组术中经空肠穿刺放置Flocare可裂式空肠造口管时间为(8.1±3.7)min,两组差异非常显著(P<0.01)。术后肛门排气恢复的时间A、B组均比对照组快(P<0.01)。PA、TF和外周血TLC均明显升高(P<0.05)。结论:食管癌两切口术后病人早期经鼻肠管和空肠造口管途径行EN支持安全、有效。而经空肠造口管行EN支持,并发症少,是病人术后EEN支持的一条更为合理的途径。
OBJECTIVE: To compare the convenience, superiority, and complications of EN-supported nasal and jejunostomy approaches in patients with esophageal cancer after two incisions. Methods: A total of 52 patients undergoing esophageal incision surgery were randomly divided into three groups: group A was a sausage tube group; group B was a jejunostomy tube group; and group C was a control group. The intraoperative nasal and jejunostomy tube placement time were recorded, the clinical manifestations and postoperative complications during EN support were observed, and the blood glucose, liver and kidney function, electrolytes and nutrition indexes of patients before and after EN were measured. Results: All patients died during the study, no serious complications, no significant changes in liver and kidney function. In group A, the time of putting nasal cannula in operation was (22.1 ± 5.9) min in group A, and the time of placing open collapsible jejunostomy tube in group B during operation was (8.1 ± 3.7) min, with significant difference between the two groups (P <0.01) ). Postoperative anal exhaust time A, B group were faster than the control group (P <0.01). PA, TF and peripheral blood TLC were significantly increased (P <0.05). CONCLUSIONS: EN is safe and effective in the early stage of nasal and jejunostomy tube after esophageal cancer incision. The jejunostomy tube EN support, fewer complications, is the patient EEN support a more reasonable way.